Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion type Assertion NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_head.
- NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion description "[Tumorigenesis led to about a twofold decrease in the relative amount of Msx2 mRNA except for ER+/PR+ immunophenotype, where no changes were observed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_provenance.
- NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion evidence source_evidence_literature NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_provenance.
- NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion SIO_000772 15945508 NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_provenance.
- NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion wasDerivedFrom befree-2016 NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_provenance.
- NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_assertion wasGeneratedBy ECO_0000203 NP498612.RAXjRwN5eRlAbxv93OUKlEbpGkixwuENR825e9i-PjsH4130_provenance.